Verastem Inc (VSTM.OQ)

VSTM.OQ on NASDAQ Stock Exchange Global Market

30 Oct 2014
Price Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for VSTM.OQ


Verastem, Inc. is a clinical biopharmaceutical company focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells. The Company also develops companion diagnostics. The Company has technology to create a stable population of cancer stem cells that it uses to screen for and identify... (more)


Beta: --
Market Cap (Mil.): $253.25
Shares Outstanding (Mil.): 25.84
Dividend: --
Yield (%): --


  VSTM.OQ Industry Sector
P/E (TTM): -- 33.49 34.41
EPS (TTM): -1.94 -- --
ROI: -55.11 18.10 17.37
ROE: -55.21 18.76 18.18
Search Stocks

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Ford Investor Services, Inc.
Provider: Reuters Investment Profile
Provider: Zacks Investment Research Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks